Komech, Ekaterina A Pogorelyy, Mikhail V Egorov, Evgeniy S Britanova, Olga V Rebrikov, Denis V Bochkova, Anna G Shmidt, Evgeniya I Shostak, Nadejda A Shugay, Mikhail Lukyanov, Sergey
...
Published in
Rheumatology (Oxford, England)
Our results suggest the involvement of a particular antigen-specific subset of CD8+ T cells in AS pathogenesis, confirming and expanding earlier findings. The high similarity of the clonotypes with the ones found in ReA implies common mechanisms for the initiation of the diseases.
Schoels, Monika M Landesmann, Uriel Alasti, Farideh Baker, Daniel Smolen, Josef S Aletaha, Daniel
Published in
Rheumatology (Oxford, England)
Three months after implementation of therapy in PsA, it is already possible to evaluate the potential for accomplishing therapeutic goals. This substantiates the choice of the 3-month assessment as essential for treatment adaptations.
Falkenburg, Willem J J Kempers, Ayla C Dekkers, Gillian Ooijevaar-de Heer, Pleuni Bentlage, Arthur E H Vidarsson, Gestur van Schaardenburg, Dirkjan Toes, René E M Scherer, Hans U Rispens, Theo
...
Published in
Rheumatology (Oxford, England)
Wilson, Ross Blakely, Tony Abbott, J Haxby
Published in
Rheumatology (Oxford, England)
Radiographic knee OA is significantly associated with worse HRQoL across most dimensions of health.
Ramon, André Pottecher, Pierre Ornetti, Paul
Published in
Rheumatology (Oxford, England)
Carter, Stuart J Tattersall, Rachel S Ramanan, Athimalaipet V
Published in
Rheumatology (Oxford, England)
Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome, which if not promptly treated, can lead rapidly to critical illness and death. HLH is termed macrophage activation syndrome (MAS) when associated with rheumatic disease (where it is best characterized in systemic JIA) and secondary HLH (sHLH) when associated with other trigg...
Arnold, Michael B Khanna, Dinesh Denton, Christopher P van Laar, Jacob M Frech, Tracy M Anderson, Marina E Baron, Murray Chung, Lorinda Fierlbeck, Gerhard Lakshminarayanan, Santhanam
...
Published in
Rheumatology (Oxford, England)
PASS may be used as a patient-centred outcome in SSc, especially as a 7-point Likert scale. Further validation is required to determine the utility as an outcome measure in trials and clinical practice.
Stober, Carmel Ye, Weiyu Guruparan, Thushyanthan Htut, Eiphyu Clunie, Gavin Jadon, Deepak
Published in
Rheumatology (Oxford, England)
Patients with PsA who are female and have metabolic syndrome-related co-morbidities have lower TNFi persistence. Although persistence was lower in patients who had switched to a second TNFi, a substantial proportion of these cases responded, advocating switching to a second TNFi as a valid therapeutic strategy.
Hewlett, Sarah Kirwan, John Bode, Christina Cramp, Fiona Carmona, Loreto Dures, Emma Englbrecht, Matthias Fransen, Jaap Greenwood, Rosemary Hagel, Sofia
...
Published in
Rheumatology (Oxford, England)
Across six European countries, the BRAF-MDQ identifies the same four aspects of fatigue, and along with the RAID, shows strong factor structure and internal consistency and moderate-good construct validity. The revised BRAF-NRS V2 shows improved construct validity and replaces the original.
Pappone, Nicola Ambrosino, Pasquale Di Minno, Matteo Nicola Dario Iervolino, Salvatore
Published in
Rheumatology (Oxford, England)